Candriam SCA’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-157,106
| Closed | -$13.3M | – | 812 |
|
|
2019
Q4 | $13.3M | Sell |
157,106
-124,394
| -44% | -$10.6M | 0.14% | 166 |
|
|
2019
Q3 | $14.1M | Buy |
281,500
+60,000
| +27% | +$3M | 0.19% | 129 |
|
|
2019
Q2 | $8.04M | Buy |
221,500
+85,000
| +62% | +$3.09M | 0.1% | 223 |
|
|
2019
Q1 | $3.82M | Hold |
136,500
| – | – | 0.05% | 372 |
|
|
2018
Q4 | $2.61M | Hold |
136,500
| – | – | 0.04% | 407 |
|
|
2018
Q3 | $4.08M | Buy |
136,500
+26,000
| +24% | +$778K | 0.05% | 366 |
|
|
2018
Q2 | $4.06M | Buy |
110,500
+22,500
| +26% | +$826K | 0.06% | 339 |
|
|
2018
Q1 | $2.9M | Hold |
88,000
| – | – | 0.05% | 397 |
|
|
2017
Q4 | $2.41M | Sell |
88,000
-14,000
| -14% | -$383K | 0.04% | 418 |
|
|
2017
Q3 | $3.78M | Buy |
102,000
+12,000
| +13% | +$444K | 0.07% | 327 |
|
|
2017
Q2 | $3.42M | Buy |
90,000
+13,000
| +17% | +$494K | 0.06% | 346 |
|
|
2017
Q1 | $3.77M | Sell |
77,000
-26,000
| -25% | -$1.27M | 0.07% | 311 |
|
|
2016
Q4 | $3.5M | Buy |
103,000
+4,000
| +4% | +$136K | 0.08% | 272 |
|
|
2016
Q3 | $3.74M | Buy |
99,000
+24,000
| +32% | +$906K | 0.09% | 242 |
|
|
2016
Q2 | $2.52M | Hold |
75,000
| – | – | 0.07% | 274 |
|
|
2016
Q1 | $2.37M | Buy |
75,000
+11,700
| +18% | +$370K | 0.06% | 297 |
|
|
2015
Q4 | $2.36M | Hold |
63,300
| – | – | 0.06% | 274 |
|
|
2015
Q3 | $2.4M | Sell |
63,300
-16,700
| -21% | -$634K | 0.06% | 311 |
|
|
2015
Q2 | $2.29M | Sell |
80,000
-35,000
| -30% | -$1M | 0.05% | 341 |
|
|
2015
Q1 | $3.22M | Buy |
115,000
+40,000
| +53% | +$1.12M | 0.06% | 324 |
|
|
2014
Q4 | $2.08M | Buy |
+75,000
| New | +$2.08M | 0.04% | 352 |
|